Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Tuberous Sclerosis Complex (TSC) and a History of Infantile Spasms (IS): Post Hoc Analysis of Phase 3 Trial GWPCARE6 (1534)

Russell Saneto,Steven Sparagana,James Wheless,F O’Callaghan,Farhad Sahebkar,Kerry Hyland,Patrick Kwan

doi:10.1212/wnl.96.15_supplement.1534

Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Tuberous Sclerosis Complex (TSC) and a History of Infantile Spasms (IS): Post Hoc Analysis of Phase 3 Trial GWPCARE6 (1534)

Russell Saneto, Steven Sparagana + Show 5 more

https://doi.org/10.1212/wnl.96.15_supplement.1534

Copy DOI

Journal: Neurology

Publication Date: Apr 13, 2021

Affiliation: Seattle Children's Hospital, The University of Texas Southwestern Medical Center, Le Bonheur Children's Hospital, University College London, GW Pharmaceuticals (United Kingdom), University of Melbourne

#History Of Infantile Spasms #Tuberous Sclerosis Complex + Show 5 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Efficacy of Add-on Cannabidiol (CBD) Treatment in Patients with Tuberous Sclerosis Complex (TSC) and a History of Infantile Spasms (IS): Post Hoc Analysis of Phase 3 Trial GWPCARE6 (1534)

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Neurology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.